What is Epilepsy? (Definition)

According to the National Institute of Neurological Disorders and Stroke (NINDS), epilepsies are a spectrum of brain disorders ranging from severe, life-threatening and disabling, to ones that are much more benign. In epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions, and behavior or sometimes convulsions, muscle spasms, and loss of consciousness. The epilepsies have many possible causes and there are several types of seizures. Anything that disturbs the normal pattern of neuron activity—from illness to brain damage to abnormal brain development—can lead to seizures.

See below for updated news and information regarding Epilepsy including new medical research, treatment options and advancements. 

Latest Epilepsy News

Epilepsy Research News: Common Epilepsies Share Genetic Overlap with Rare Types

(SOURCE: COLUMBIA UNIVERSITY MEDICAL CENTER) - Precision medicine-based therapy may apply to a wider range of epilepsies. An international study led by Columbia University Medical Center (CUMC) and NewYork-Presbyterian has found that several genes previously implicated only in rare, severe forms of pediatric epilepsy also contribute to common forms of the disorder. “Our findings raise hopes that the emerging paradigm for the ...
Read More

Epileptic Encephalopathy Research News: Gene discovered to cause rare, severe neurological disease

(Source: McGill University) - Epileptic encephalopathy linked to protein trafficking gene. Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells. The scientists from the Montreal Neurological Institute and Hospital at McGill University, led by Peter McPherson, along with collaborators in Saudi Arabia, Jordan, Germany, and at ...
Read More

Epilepsy Treatment News: Researchers Gain Better Understand Why Seizures Continue in Some Patients After Surgery

(UNIVERSITY OF LIVERPOOL) According to a recent press release, new research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even after surgery ...
Read More

Epilepsy News: Study Shows a Link Between Mothers with Rheumatoid Arthritis and Children with Epilepsy

(AMERICAN ACADEMY OF NEUROLOGY) According to a recent press release, a new study shows a link between mothers with rheumatoid arthritis and children with epilepsy. The study is published in the November 16, 2016, online issue of Neurology®, a medical journal of the American Academy of Neurology. Rheumatoid arthritis (RA) is an autoimmune disease that causes the body's own immune system ...
Read More

Epilepsy News: Scientists Find Compound Shows Potential to Protect Against Febrile Seizures

(EMORY HEALTH SCIENCES) According to a recent press release, the compound huperzine A can increase resistance to induced seizures in mouse models of genetic epilepsy, scientists at Emory University School of Medicine have found. In particular, huperzine A shows potential for protecting against febrile seizures, which are a feature of both Dravet syndrome, a severe form of childhood epilepsy, and ...
Read More

Epilepsy News: Study Shows Behavior Predicts Severe Psychiatric Conditions in Children with Epilepsy

(Epilepsy News Today) According to a recent article published in Epilepsy News Today, the behavior of children with epilepsy predicts those who are at higher risk to develop multiple and severe psychiatric conditions, according to an analysis of information gathered from their parents ...
Read More

Lead Compound BIS-001 Eliminates Seizures in Majority of Animals in Models of Dravet Syndrome

(PRNewswire) Biscayne Pharmaceuticals, Inc., today reported that a new scientific publication shows that lead compound BIS-001 can eliminate all seizures in the majority of animals in models of the catastrophic type of epilepsy known as Dravet syndrome. BIS-001 is a clinical-stage, highly potent agent with a novel mechanism of action that is a synthetic form of huperzine A, an extract of ...
Read More